Abstract
The United States is a federal union with separate state jurisdictions. In part owing to the sometimes heated debate about public support for human embryonic stem-cell (ESC) research, there has been restricted federal support and little central regulation of this research to date. Instead, guidelines developed by scientific organizations have set principles for oversight and good practice for this research. These guidelines are functioning well, have influenced developing state regulations and, one hopes, will affect any future federal regulation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Stakeholder Involvement in the Governance of Human Genome Editing in Japan
Asian Bioethics Review Open Access 26 April 2023
-
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis
npj Regenerative Medicine Open Access 11 September 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
Shamblott, M. J. et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl Acad. Sci. USA 95, 13726–13731 (1998).
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Takahashi, K. et al. Induction of pluripotent stem cells from adult fibroblasts by defined factors. Cell 131, 1–12 (2007).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
National Bioethics Advisory Commission. Ethical Issues in Human Stem Cell Research. I. Report and recommendations. National Bioethics Advisory Commission [online], (1999).
National Institutes of Health. Notice NOT-OD-01–059: funding of research using specified existing human embryonic stem cells. National Institutes of Health [online], (2001).
Streiffer, R. Informed consent and federal funding for stem cell research. Hastings Cent. Rep. 38, 40–47 (2008).
National Research Council and Institute of Medicine. Guidelines for Human Embryonic Stem Cell Research. National Academies of Science [online], (2005).
National Research Council and Institute of Medicine. 2007 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research. National Academies of Science [online], (2007).
National Research Council and Institute of Medicine. 2008 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research. National Academies of Science [online], (2008).
Moreno, J. D. & Hynes, R. O. Guidelines for human embryonic stem cell research. Nature Biotech. 23, 793–794 (2005).
International Society for Stem Cell Research. Guidelines for the Conduct of Human Embryonic Stem Cell Research, version 1. International Society for Stem Cell Research [online], (2006).
Daley, G. Q. et al. The ISSCR guidelines for human embryonic stem cell research. Science 315, 603–604 (2007).
Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132–3142 (2008).
Stayn, S. Navigating emerging legal requirements in human embryonic stem cell research. Med. Res. Law Policy Rep. 5, 297–301 (2006).
Stayn, S. A guide to state laws on hESC research and a call for interstate dialogue. Med. Res. Law Policy Rep. 5, 718–725 (2006).
Nishikawa, S.-I. et al. The promise of human induced pluripotent stem cells for research and therapy. Nature Rev. Mol. Cell Biol. 9, 725–729 (2008).
Acknowledgements
The author would like to thank A. Charo, G. Daley, F. Sharples, S. Stayn and K. Wilson for their helpful suggestions on the content of this article.
Author information
Authors and Affiliations
Related links
Glossary
- Chimaera
-
An organism that is composed of cells from at least two genetically different sources. The cells could be from the same or separate species.
- Cybrid
-
A cell with a nucleus from one cell and cytoplasm from another. For example, it is possible to reprogramme a somatic cell nucleus by inserting it into the cytoplasm of an oocyte or another pluripotent cell.
- Embryonic stem cell
-
(ESC). A primitive (undifferentiated) cell that is derived from early embryos. These are usually derived from the blastocyst (50–250-cell stage), but are sometimes derived from the morula (16–32-cell stage). ESCs have the potential to become a wide range of specialized cell types.
- Induced pluripotent stem (iPS) cell
-
A cell that has been derived from a somatic cell by reprogramming the nucleus to induce pluripotency, using exogenous genes or other factors.
- Nuclear transfer
-
(NT). Replacing the nucleus of a cell with the nucleus of another cell.
- Pluripotency
-
The capacity of a cell to develop into cells of all three germ layers (endoderm, ectoderm and mesoderm) and most cells and tissues of an embryo.
- Reproductive cloning
-
The generation of viable organisms from cloned pluripotent cells.
- Reprogramming
-
The alteration of the epigenetic programme of a nucleus or cell to change its differentiation capacity. For example, a differentiated cell of limited potential is reprogrammed by nuclear transfer (NT) or by the introduction of exogenous genes (currently using retroviruses but alternative methods are being researched).
- Retroviruses
-
RNA viruses that are used as carriers or vectors to introduce genes into the genomes of cells. Retroviruses are used in basic research and have been used in gene therapy, in which they have been reported to induce cancer in a limited number of patients.
- Somatic cell
-
Any cell other than a germ cell or a germ-cell precursor.
- Stem cell
-
A cell that has the ability to divide extensively in vivo or in culture and to give rise to specialized cells.
Rights and permissions
About this article
Cite this article
Hynes, R. US policies on human embryonic stem cells. Nat Rev Mol Cell Biol 9, 993–997 (2008). https://doi.org/10.1038/nrm2528
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm2528
This article is cited by
-
Stakeholder Involvement in the Governance of Human Genome Editing in Japan
Asian Bioethics Review (2023)
-
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis
npj Regenerative Medicine (2020)
-
China's policies on stem cell research: an opportunity for international collaborations
Nature Reviews Molecular Cell Biology (2009)
-
The regulation of human embryo and stem-cell research in the United Kingdom
Nature Reviews Molecular Cell Biology (2008)